BACARDI-LIMITED
30.3.2021 13:02:15 CEST | Business Wire | Press release
After decades spent carefully building sustainable partnerships with farmers and suppliers, BOMBAY SAPPHIRE, the iconic premium gin from family-owned Bacardi Limited, is proud to announce that all 10 of its botanical ingredients are on track to be certified sustainable in 2021. With the suppliers of eight already certified according to the For Life standard, the goal is for the remaining two producers – for grains of paradise from Ghana and liquorice from China – to be certified in the months which follow the lifting of travel restrictions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210330005556/en/
This news is a major step towards Bacardi, the largest privately-held spirits company in the world, achieving its 2025 goal of sourcing 100% of its key ingredients from sustainably certified suppliers.
The 10 botanicals, which include juniper from Tuscany, coriander from Morocco, lemon peel from Spain and cubeb berries from Java, are hand selected by BOMBAY SAPPHIRE Master of Botanicals Ivano Tonutti to create the gin’s fresh, bright taste.
Only the finest quality botanicals are selected by Ivano and his work does not end there. The For Life certification awarded by Ecocert S.A., the world’s leading specialist in the certification of sustainable practices, recognizes the commitment of Ivano and Bacardi to only work with suppliers who act responsibly and ensure a sustainable future for farmers, their communities and the environment.
BOMBAY SAPPHIRE has pioneered sustainability in the spirits industry. The brand has long invested in new innovations offering creative solutions to complex challenges. When the BOMBAY SAPPHIRE distillery opened in Laverstoke, England, in 2014 it set a new standard for sustainability by showcasing many such innovations – the distillery’s design was rated ‘outstanding’ by BREEAM , the most recognized environmental assessment for buildings.
“We take a 360-degree approach to sustainability,” says Ivano Tonutti. ”It’s our responsibility to care as much about the farmers and their communities as we do the botanicals they grow and harvest for BOMBAY SAPPHIRE. By looking after their well-being and investing in sustainable farming practices, we are helping to protect the environment and their livelihoods for generations to come.”
An example of this in practice is the village in Ghana where, over a number of years, Bacardi has worked with AIESEC, a local non-governmental organization, to help the community establish itself as an independent farming cooperative – from installing a water pump, which now supplies the village with fresh water, to recruiting an agronomist for expert advice and guidance. This year, the village will harvest its first crop of grains of paradise for BOMBAY SAPPHIRE.
“For Life certification gives consumers peace of mind that ingredients are coming from organizations committed to continuous improvement,” says Ecocert CEO Philippe Thomazo. “For Life means that suppliers growing and harvesting the certified botanicals for BOMBAY SAPPHIRE are acting responsibly in every respect.”
Natasha Curtin, VP BOMBAY SAPPHIRE, says: “I am incredibly proud of this latest achievement by Ivano and his team but as an industry, we must all invest in a more sustainable future. Ivano has spent more than 20 years building close relationships with our farmers and suppliers around the world. With his experience and expertise, we have created a blueprint for the sustainable sourcing of botanicals, which we hope will inspire others to do the same.”
Bacardi worked closely with its suppliers to help them achieve For Life certification. To be certified, suppliers must commit to continuous improvement in the following areas:
- the well-being of the people involved in the harvesting and supply of the botanicals;
- the reduction of their environmental impact;
- their responsible purchasing practices;
- and sustainable development at a local level and key stages in the supply chain.
Find out more about the sustainability commitments of Bacardi and its vision to become the most environmentally responsible global spirits company at https://www.bacardilimited.com/corporate-responsibility/environment/ .
Always drink responsibly.
About BOMBAY SAPPHIRE gin
BOMBAY SAPPHIRE, the world's number one premium gin, is created with a unique combination of 10 botanical ingredients sourced from around the globe. In the historic still houses of the BOMBAY SAPPHIRE distillery in Hampshire, England, spirit vapour passes through perforated copper baskets filled by hand with the 10 botanicals. Through this signature distillation process, called vapour infusion
, BOMBAY SAPPHIRE perfectly captures the natural, aromatic flavors of each botanical which results in the gin's fresh, bright taste. Awarded a double gold medal in the 2017 San Francisco World Spirits Competition, BOMBAY SAPPHIRE is consistently recognized for crafting the finest quality gin. For more information, please explore www.bombaysapphire.com
.
BOMBAY SAPPHIRE is part of the portfolio of Bacardi Limited, with global headquarters in Hamilton, Bermuda. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.
About Bacardi Limited
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded nearly 160 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com
or follow us on Twitter
, LinkedIn
or Instagram
.
About Ecocert Group
With over 30 years of commitment to sustainability and to the development of organic farming worldwide, Ecocert provides stakeholders with support in understanding, implementing and promoting sustainable practices through training, consulting and independent certification services. Ecocert only offers a range of selected, recognized, and demanding standards with high environmental and societal criteria. For organizations willing to go further in the transition, Ecocert also develops innovative programs with higher requirements (Fair For Life, For Life, En Cuisine, etc.). Today the group is also a world leading company in the certification of organic agriculture and cosmetic, present in more than 130 countries through an international network of 31 subsidiaries with over 1,700 collaborators. To find out more on how Ecocert acts for a sustainable world, please visit: www.ecocert.com
or follow Ecocert on LinkedIn
or Facebook
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210330005556/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
